| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 159, Issue 6 2849-2857, Copyright © 1997 by American Association of Immunologists
ARTICLES |
A Sartori, MA Oliveira, P Scott and G Trinchieri
Wistar Institute, Philadelphia, PA 19104, USA.
Immunity against the intracellular protozoan Leishmania species is highly dependent on Th1 development. We have previously shown that IL- 12 is a powerful and probably obligatory factor for Th1 cell generation and proliferation. We also observed that the experimental infection of C3H and BALB/c mice with Leishmania major is associated with IL-12 production in vivo. Now we demonstrate that metacyclic L. major promastigotes are poor inducers of IL-12 in vitro in fresh human PBMC and monocytes. In addition, we show that the ability of this pathogen to induce IL-12 and other cytokines is modulated by the metacyclogenic process, which had previously not been recognized. In contrast to the infective parasites (metacyclic promastigotes), the procyclic promastigotes collected at the logarithmic phase of the culture displayed a striking ability to induce IL-12, IFN-gamma, TNF-alpha, and IL-10. Despite this differential effect of procyclic and metacyclic parasites in terms of IL-12 induction, both stages were inhibitory for IL-12 production induced by Staphylococcus aureus. The ability of procyclic promastigotes and, to a much lesser extent, that of metacyclic promastigotes to induce IL-12 were enhanced by pretreatment of monocytes in a cytokine milieu containing IFN-gamma, IL-4, IL-13, or granulocyte-macrophage CSF or by neutralization of endogenous IL-10. Our results suggest the development of an evasion mechanism as the Leishmania promastigotes mature to infectious forms and the possibility of using Ags derived from procyclic promastigotes for immunization procedures.
This article has been cited by other articles:
|
|
 |
|
  O. E. Akilov, R. E. Kasuboski, C. R. Carter, and M. A. McDowell The role of mannose receptor during experimental leishmaniasis J. Leukoc. Biol., May 1, 2007; 81(5): 1188 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Woelbing, S. L. Kostka, K. Moelle, Y. Belkaid, C. Sunderkoetter, S. Verbeek, A. Waisman, A. P. Nigg, J. Knop, M. C. Udey, et al. Uptake of Leishmania major by dendritic cells is mediated by Fc{gamma} receptors and facilitates acquisition of protective immunity J. Exp. Med., January 23, 2006; 203(1): 177 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. P. Oliveira, G. M. A. C. Lima, M. T. Shio, P. J. M. Leenen, and I. A. Abrahamsohn Immature macrophages derived from mouse bone marrow produce large amounts of IL-12p40 after LPS stimulation J. Leukoc. Biol., November 1, 2003; 74(5): 857 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lang, N. Courret, J.-H. Colle, G. Milon, and J.-C. Antoine The Levels and Patterns of Cytokines Produced by CD4 T Lymphocytes of BALB/c Mice Infected with Leishmania major by Inoculation into the Ear Dermis Depend on the Infectiousness and Size of the Inoculum Infect. Immun., May 1, 2003; 71(5): 2674 - 2683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kawamura, H. Gatanaga, D. L. Borris, M. Connors, H. Mitsuya, and A. Blauvelt Decreased Stimulation of CD4+ T Cell Proliferation and IL-2 Production by Highly Enriched Populations of HIV-Infected Dendritic Cells J. Immunol., April 15, 2003; 170(8): 4260 - 4266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. McDowell, M. Marovich, R. Lira, M. Braun, and D. Sacks Leishmania Priming of Human Dendritic Cells for CD40 Ligand-Induced Interleukin-12p70 Secretion Is Strain and Species Dependent Infect. Immun., August 1, 2002; 70(8): 3994 - 4001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Delorenzi, L. Freire-de-Lima, C. R. Gattass, D. de Andrade Costa, L. He, M. E. Kuehne, and E. M. B. Saraiva In Vitro Activities of Iboga Alkaloid Congeners Coronaridine and 18-Methoxycoronaridine against Leishmania amazonensis Antimicrob. Agents Chemother., July 1, 2002; 46(7): 2111 - 2115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Chen, P. A. Darrah, and D. M. Mosser Vaccination against the Intracellular Pathogens Leishmania major and L. amazonensis by Directing CD40 Ligand to Macrophages Infect. Immun., May 1, 2001; 69(5): 3255 - 3263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. I. Brodskyn, G. K. DeKrey, and R. G. Titus Influence of Costimulatory Molecules on Immune Response to Leishmania major by Human Cells In Vitro Infect. Immun., February 1, 2001; 69(2): 665 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lira, M. Doherty, G. Modi, and D. Sacks Evolution of Lesion Formation, Parasitic Load, Immune Response, and Reservoir Potential in C57BL/6 Mice following High- and Low-Dose Challenge with Leishmania major Infect. Immun., September 1, 2000; 68(9): 5176 - 5182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Quinones, S. K. Ahuja, P. C. Melby, L. Pate, R. L. Reddick, and S. S. Ahuja Preformed Membrane-associated Stores of Interleukin (IL)-12 Are a Previously Unrecognized Source of Bioactive IL-12 That Is Mobilized within Minutes of Contact with an Intracellular Parasite J. Exp. Med., August 14, 2000; 192(4): 507 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Belkaid, S. Mendez, R. Lira, N. Kadambi, G. Milon, and D. Sacks A Natural Model of Leishmania major Infection Reveals a Prolonged ""Silent"" Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity J. Immunol., July 15, 2000; 165(2): 969 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Marovich, M. A. McDowell, E. K. Thomas, and T. B. Nutman IL-12p70 Production by Leishmania major-Harboring Human Dendritic Cells Is a CD40/CD40 Ligand-Dependent Process J. Immunol., June 1, 2000; 164(11): 5858 - 5865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chougnet, S. S. Cohen, T. Kawamura, A. L. Landay, H. A. Kessler, E. Thomas, A. Blauvelt, and G. M. Shearer Normal Immune Function of Monocyte-Derived Dendritic Cells from HIV-Infected Individuals: Implications for Immunotherapy J. Immunol., August 1, 1999; 163(3): 1666 - 1673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-i. Mizuno, K. Akashi, K. Ohshima, H. Iwasaki, T. Miyamoto, N. Uchida, T. Shibuya, M. Harada, M. Kikuchi, and Y. Niho Interferon-{gamma} Prevents Apoptosis in Epstein-Barr Virus-Infected Natural Killer Cell Leukemia in an Autocrine Fashion Blood, May 15, 1999; 93(10): 3494 - 3504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Alexander, A. Satoskar, and D. Russell Leishmania species: models of intracellular parasitism J. Cell Sci., January 9, 1999; 112(18): 2993 - 3002. [Abstract] [PDF]
|
|
|
|
|
|
E. von Stebut, Y. Belkaid, T. Jakob, D. L. Sacks, and M. C. Udey Uptake of Leishmania major Amastigotes Results in Activation and Interleukin 12 Release from Murine Skin-derived Dendritic Cells: Implications for the Initiation of Anti-Leishmania Immunity J. Exp. Med., October 19, 1998; 188(8): 1547 - 1552. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
